Panacea Life Sciences Holdings, Inc. (PLSH)

Market Cap	821.36K
Revenue (ttm)	2.76M
Net Income (ttm)	-7.67M
Shares Out	21.22M
EPS (ttm)	-0.45
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,999
Average Volume	1,067
Open	0.0324
Previous Close	0.0387
Day's Range	0.0324 - 0.0387
52-Week Range	0.0250 - 0.1400
Beta	3.19
RSI	52.81
Earnings Date	Aug 15, 2025

About PLSH

Panacea Life Sciences Holdings, Inc., operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals. It provides a range of products, including Nitro Kava, Kratom, hemp, VAPE products, and various beverages that focuses on promoting alternative health and wellness. The company also offers natural remedies under the PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure, and PANA Life brand names. It ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2008
• Employees: 40
• Stock Exchange: OTCMKTS
• Ticker Symbol: PLSH

Financial Performance

In 2023, PLSH's revenue was $2.38 million, an increase of 46.59% compared to the previous year's $1.63 million. Losses were -$8.02 million, -12.33% less than in 2022.